A nurse is preparing a plan of care for a client who is postoperative following a cochlear implant insertion. Which of the following instructions should the nurse include in the plan of care?

A. A client transferred to the medical unit 1 hour ago, after staying 3 days in the ICU for severe blood pressure issues: This client is at the greatest risk for developing delirium due to several factors: recent transfer from the intensive care unit (ICU), history of severe blood pressure issues requiring ICU admission, and the potential for experiencing significant physiological and psychological stressors during the ICU stay. Patients who have been in the ICU are at increased risk for delirium due to factors such as sedative use, mechanical ventilation, and critical illness.

B. A client who has been on the medical unit for a week following a car accident and is waiting for transfer to a rehab facility when a bed becomes available: While this client may have experienced significant trauma from the car accident, they have been stable on the medical unit for a week, which reduces the immediate risk of developing delirium compared to the client recently transferred from the ICU. However, ongoing assessment and monitoring are still necessary.

C. A client who has been NPO for 3 hours, receiving IV fluids, and has not been prescribed any medications: While fasting and receiving IV fluids may contribute to dehydration, which can increase the risk of delirium, this client does not have the same level of acuity or recent history of critical illness as the client transferred from the ICU. Additionally, the absence of prescribed medications reduces the risk of medication-related delirium.

D. A client who is 4 days postoperative following knee surgery and scheduled for discharge home later this morning: This client is in the subacute phase of recovery and is scheduled for discharge home, indicating stability and reduced risk of developing delirium compared to the client recently transferred from the ICU. However, postoperative patients are still at risk for delirium, particularly in the immediate postoperative period, and should be monitored accordingly.

A. "Medications for Alzheimer's disease will help to increase my energy levels": This statement is not accurate. Medications for Alzheimer's disease, such as cholinesterase inhibitors (e.g., donepezil, rivastigmine) and memantine, are not intended to increase energy levels. Their primary goal is to improve cognitive function and help manage symptoms associated with Alzheimer's disease, but they do not directly affect energy levels.

B. "Medications for Alzheimer's disease will help slow the progression of my disease": This statement is correct. Medications used to treat Alzheimer's disease, such as cholinesterase inhibitors and memantine, are aimed at slowing the progression of cognitive decline and managing symptoms associated with the disease. While these medications cannot cure Alzheimer's disease, they can help improve cognitive function and quality of life for some individuals.

C. "Medications for Alzheimer's disease will help me remember what I forgot": This statement oversimplifies the effects of Alzheimer's medications. While these medications may help improve memory and cognition to some extent, they are not capable of restoring lost memories or reversing the effects of significant memory impairment caused by Alzheimer's disease.

D. "Medications for Alzheimer's disease will cure the disease": This statement is incorrect. Currently, there is no cure for Alzheimer's disease. Medications used to treat Alzheimer's, such as cholinesterase inhibitors and memantine, can help manage symptoms and slow disease progression, but they do not cure the underlying condition.